Experts provide a deep dive into what Health Technology Assessment (HTA) agencies do and the types of literature reviews they do.
As the focus on evidence-based decision-making in healthcare has increased, the role and scope of Health Technology Assessment (HTA) has evolved. The rising number of new pharmaceuticals, medical devices, and other health innovations, along with their novelty and increasing complexity, have led to an increased demand for assessment. How evidence synthesis fits in with Cost Effectiveness Analysis and Budget Impact Assessment and their current challenges with literature review use to support HTAs is discussed.
Presenters

Chris Waters-Banker
Dr. Chris Waters-Banker is a consultant at Maple Health Group with over a decade of experience in clinical scientific research. She has extensive knowledge in health research methodology across both basic and applied clinical sciences, with expertise in musculoskeletal conditions and immunology.

Maria Arregui
Maria Arregui, PhD, is an Assistant Director on the HTA Reviews team at Xcenda. In this role, she supports literature reviews aimed at understanding the clinical and economic burden of disease and helps manufacturers prepare for regulatory and reimbursement submissions using systematic literature review (SLR) and network meta-analysis (NMA) techniques.

Rajshree Pandey
Dr. Rajshree Pandey is an Associate Director at Curta Inc and serves as the evidence synthesis lead. She has extensive experience in evidence synthesis methods including systematic literature reviews, indirect treatment comparisons, and public health research.

Lee-Anne Bourke
Lee-Anne Bourke is a librarian with a keen interest in bibliometric trends, literature review methodologies and information management. She joined Evidence Partners in 2021 as an Account Executive. She is passionate about research and is a published author of Cochrane, Campbell and JBI systematic reviews.

Patti Peeples
Patti is a health economist, pharmacist and industry leader with 35 years of experience in health care value, evidence and access.
Sponsor

DistillerSR
Content Partners

HealthEconomics.com
HealthEconomics.com is the world’s largest Connected Community™ for Value, Evidence and Access in the life sciences industry.
HealthEconomics.com provides a single global link to the health economic and outcomes research (HEOR), real-world evidence (RWE), and Market Access (MA) stakeholder communities. Since 1993, we have provided unparalleled access to drive business, improve knowledge, and connect researchers and payer decision-makers world-wide.
Our 27,000 engaged readers rely on HealthEconomics.com as the most reliable, credible and curated digital hub for the latest news, insights, educational opportunities, and industry benchmarks in HEOR, RWE and MA. Our advertisers, numbering more than 500 with a 91% retention rate, depend upon HealthEconomics.com for best-in-class global brand awareness and business development solutions. Our aim is to connect people with expert-driven content and resources — all in one place — with the corporate mission to advance communication about healthcare value.
































































